Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More 05/17/13 San Diego
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More 04/04/13 San Diego
Optimer Shares Soar Amid Reports of Buyout Interest 04/02/13 San Diego
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
San Diego Life Sciences Roundup: Optimer, Zogenix, MediciNova, & More 03/01/13 San Diego
Optimer Board Ousts CEO, Brings Back Former Pfizer CEO McKinnell 02/27/13 San Diego
San Diego Life Sciences Roundup: Optimer, Volcano, Avelas Bio, & More 12/07/12 San Diego
San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More 10/19/12 San Diego
San Diego Life Sciences Roundup: Optimer, CareFusion, Senomyx & More 10/11/12 San Diego
SD Life Sciences Roundup: Optimer, Illumina, & Deals, Deals, Deals 04/12/12 San Diego
Optimer Discloses Shakeup Prompted by Chairman’s Deal in Taiwan 04/09/12 National
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics 02/01/12 San Francisco
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic 01/31/12 San Diego
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More 12/16/11 San Diego
Optimer Wins EU Approval for New Antibiotic 12/12/11 San Diego
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Optimer Pulls in $10.6M in Sales, With Commercial Rollout of New Antibiotic 11/03/11 San Diego
Elevation Partners Grabs $17M, NanoSort Wins Grants, NIH Collaborates with Afraxis on Rare Disease R&D, & More San Diego Life Sciences News 09/29/11 San Diego
Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News 07/21/11 San Diego
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News 06/02/11 San Diego
Optimer Wins FDA Approval of New Antibiotic for Hospital Infections 05/27/11 San Diego
Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic 05/27/11 San Diego
New Health IT Startup Targets Military Programs, Allylix Sniffs New Market for Nootkatone, Biocept Builds Team, & More San Diego Life Sciences News 05/05/11 San Diego
Optimer Spokeswoman Killed 05/04/11 San Diego
Optimer Inks Potential $47.5M-Plus Deal with Cubist to Help Sell Antibiotic 04/06/11 San Diego
Optimer Wins FDA Panel Nod, Still Wrestling With Language to Describe Benefit 04/05/11 San Diego
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made 04/04/11 National
Optimer Raises $77.6M, Former Sequenom Patent Agent Pleads Guilty, IPO Lineup Includes San Diego’s Ambit and IASO Pharma, & More San Diego Life Sciences News 02/17/11 San Diego
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.